Contribution of benzodiazepines in dental care of patients with special needs

• Bruna-Lavinas-Sayed Picciani ^[3] ; Bruna-Michalski dos Santos ^[1] ; Geraldo-Oliveira Silva-Júnior ^[4] ; Marcello-Alves Marinho ^[2] ; Eliane-Garritano Papa ^[2] ; Marcelo-Daniel-Brito Faria ^[4] ; Luciana-Freitas Bastos ^[5] ; Cresus-Vinícius-Depes de Gouvêa ^[2]
  1. [1] Universidade do Estado do Rio de Janeiro

     Universidade do Estado do Rio de Janeiro

     Brasil

     
  2. [2] Universidade Federal Fluminense

     Universidade Federal Fluminense

     Brasil

     
  3. [3] Postgraduate Program in Dentistry, Universidade Federal Fluminense, Nova Friburgo, RJ, Brazil; Dental Center for Patients with Special Needs, Rir Institute, Rio de Janeiro, RJ, Brazil; Center of Dental Radiology and Care to Patients with Special Needs, Piquet Carneiro Polyclinic, Universidade do Estado do Rio de Janeiro, RJ, Brazil
  4. [4] Center of Dental Radiology and Care to Patients with Special Needs, Piquet Carneiro Polyclinic, Universidade do Estado do Rio de Janeiro, RJ, Brazil; Department of Diagnosis and Therapeutics, School of Dentistry, Universidade do Estado do Rio de Janeiro, RJ, Brazil
  5. [5] Center of Dental Radiology and Care to Patients with Special Needs, Piquet Carneiro Polyclinic, Universidade do Estado do Rio de Janeiro, RJ, Brazil; Department of Preventive and Community Dentistry, School of Dentistry, Universidade do Estado do Rio de Janeiro, RJ, Brazil

  Mostrar afiliaciones +
• Localización: Journal of Clinical and Experimental Dentistry, ISSN-e 1989-5488, Vol. 11, Nº. 12 (November), 2019, págs. 1170-1174
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Conscious sedation in dental treatment of patients with special needs (PNEs) has the purpose of controlling events such as anxiety and fear, as well as promoting muscle relaxation and mastery of uncoordinated movements. Benzodiazepines (BZDs) are among the most used drugs due to their anxiolytic, hypnotic and sedative properties. The objective of this investigation is to demonstrate a study on the contribution of conscious sedation with BZD in PNEs.

    The study included 40 PNEs, non-collaborators, submitted to conscious oral sedation with Midazolam (0.5 mg/kg) for dental treatment, receiving vital signs monitoring in the pre, trans and postoperative periods.

    Male patients were more frequent with 70% of the cases, with a mean age of 18 years. As for medical diagnosis, autism and mental deficiency were the most prevalent. The most performed procedures were restoration (32%) and exodontia (30%). There was a statistically significant reduction in systolic and diastolic blood pressure parameters (p<0.05) in the transoperative and postoperative periods when compared to the preoperative period. Conscious sedation with BZDs resulted in 83% positive responses.

    The results demonstrate that this technique is safe and effective, and can be used in outpatient care for PNEs. However, the risk/benefit ratio should be correctly evaluated.